Revvity, Inc. (RVTY)

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Apr 5, 2026	Dec 28, 2025	Dec 29, 2024	Dec 31, 2023	Jan 1, 2023	Jan 2, 2022	Jan 3, 2021	Dec 29, 2019	Dec 31, 2018	Dec 31, 2017	Jan 1, 2017	Jan 3, 2016	Dec 28, 2014
Total Diagnostics Revenue (Pre-Q3 2022)	1.45B	1.42B	1.36B
Total Diagnostics Revenue (Pre-Q3 2022) Growth	1.75%	5.05%	4.96%
Revenue (Other)	1.45B	1.43B	1.40B
Revenue (Total)	2.90B	2.86B	2.76B
Revenue (Total) Growth	1.62%	3.67%	0.16%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Apr 5, 2026	Dec 28, 2025	Dec 29, 2024	Dec 31, 2023	Jan 1, 2023	Jan 2, 2022	Jan 3, 2021	Dec 29, 2019	Dec 31, 2018	Dec 31, 2017	Jan 1, 2017	Jan 3, 2016	Dec 28, 2014
Life Sciences Revenue (Post-Q2 2022)	1.45B	1.43B	1.40B
Life Sciences Revenue (Post-Q2 2022) Growth	1.50%	2.32%	-4.09%
Total Diagnostics Revenue (Pre-Q3 2022)	1.45B	1.42B	1.36B
Total Diagnostics Revenue (Pre-Q3 2022) Growth	1.75%	5.05%	4.96%
Revenue (Total)	2.90B	2.86B	2.76B
Revenue (Total) Growth	1.62%	3.67%	0.16%

Revenue Breakdown 3

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Apr 5, 2026	Dec 28, 2025	Dec 29, 2024	Dec 31, 2023	Jan 1, 2023	Jan 2, 2022	Jan 3, 2021	Dec 29, 2019	Dec 31, 2018	Dec 31, 2017	Jan 1, 2017	Jan 3, 2016	Dec 28, 2014
Total Diagnostics Revenue (Pre-Q3 2022)	1.45B	1.42B	1.36B
Total Diagnostics Revenue (Pre-Q3 2022) Growth	1.75%	5.05%	4.96%
Total Product Revenue	2.41B	2.39B	2.34B
Total Product Revenue Growth	0.94%	2.21%	-3.21%
Total Service Revenue	490.02M	466.07M	416.82M
Total Service Revenue Growth	5.14%	11.82%	24.54%
Revenue (Total)	2.90B	2.86B	2.76B
Revenue (Total) Growth	1.62%	3.67%	0.16%

EBIT 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Apr 5, 2026	Dec 28, 2025	Dec 29, 2024	Dec 31, 2023	Jan 1, 2023	Jan 2, 2022	Jan 3, 2021	Dec 29, 2019	Dec 31, 2018	Dec 31, 2017	Jan 1, 2017	Jan 3, 2016	Dec 28, 2014
Life Sciences Operating Income (Post-Q2 2022)	456.53M	458.26M	467.28M
Life Sciences Operating Income (Post-Q2 2022) Growth	-0.38%	-1.93%	-8.78%
Diagnostics Operating Income (Pre-Q3 2022)	346.27M	344.17M	353.94M
Diagnostics Operating Income (Pre-Q3 2022) Growth	0.61%	-2.76%	18.76%
Operating Income (Total)	360.29M	356.64M	346.74M
Operating Income (Total) Growth	1.03%	2.85%	15.36%

EBIT 3

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014
Period Ending	Apr 5, 2026	Dec 28, 2025	Dec 29, 2024	Dec 31, 2023	Jan 1, 2023	Jan 2, 2022	Jan 3, 2021	Dec 29, 2019	Dec 31, 2018	Dec 31, 2017	Jan 1, 2017	Jan 3, 2016	Dec 28, 2014
Diagnostics Operating Income (Pre-Q3 2022)	346.27M	344.17M	353.94M
Diagnostics Operating Income (Pre-Q3 2022) Growth	0.61%	-2.76%	18.76%
Operating Income (Total)	360.29M	356.64M	346.74M
Operating Income (Total) Growth	1.03%	2.85%	15.36%

Data Source: Fiscal.ai Last updated: May 12, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Data Sources Report a data error